Genome-Based Therapeutics: Targeted Drug Discovery and Development
Publisher: National Academies Press 2012
Number of pages: 89
Description:
Objectives: To examine the impact of and investment in genetic and genomic technologies and data in drug discovery and development; To examine and discuss the challenges for incorporating genomic technologies into drug development and to explore solutions to remedy those challenges; To discuss and explore how innovative, novel, and global partnerships between academia, industry, foundations, and government can enable the use of genomic information for more efficient and effective drug discovery and development programs.
Download or read it online for free here:
Download link
(940KB, PDF)
Similar books
The Emerging Discipline of Quantitative Systems Pharmacologyby Tarek A Leil, Sergey Ermakov (eds) - Frontiers Media S.A.
Quantitative Systems Pharmacology is still in its infancy, but has tremendous potential to change the way we approach biomedical research. QSP is really the integration of two disciplines: 'Systems Biology' and 'Quantitative Pharmacology'.
(4674 views)
Pharmacology and Therapeuticsby Sivakumar Joghi Thatha Gowder (ed.) - InTech
This book covers six sections: Molecular Modeling and Bio-molecular Pharmacology, Immunopharmacology, Environmental Pharmacology and Toxicology, Nanotechnology and Chemotherapy, Drugs and Drug Delivery System and Addiction Pharmacology.
(8025 views)
Medicinal Chemistry and Drug Designby Deniz Ekinci - InTech
This book contains an overview focusing on the research area of enzyme inhibitors, molecular aspects of drug metabolism, organic synthesis, prodrug synthesis, in silico studies and chemical compounds used in relevant approaches.
(19841 views)
Improving and Accelerating Therapeutic Development for Nervous System Disorders- National Academies Press
The aim was to examine opportunities to accelerate drug development for nervous system drug discovery. Workshop participants discussed challenges in neuroscience research for enabling faster entry of potential treatments into first-in-human trials.
(6585 views)